Mirvaso to be a $100 million drug for Galderma
A revealing interview with the Galderma USA President Francois Fournier has just been published by the Dallas Fort Worth Healthcare Daily.
read more –> Mirvaso to be a $100 million drug for Galderma
EMROSI (was DFD-29) has been approved for rosacea
2 months ago